Fig. 4From: Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method studyIndications and influencing factors in the participating medical centers for offering thoracic radiotherapy following induction chemoimmunotherapy (A), and dose and fractionation schedules commonly used in thoracic radiotherapy for extensive-stage small cell lung cancer (ES-SCLC) (B). *Other include: aggressive mediastinal mass at ES-SCLC diagnosis; patients with a metastasis in complete remission but showing persistent disease on positron emission tomographyBack to article page